Arvinas News and Activities

Presence

Arvinas develops medicines that use targeted protein degradation to treat cancer and other serious diseases. Its services include drug discovery and clinical development for patients, healthcare providers, and pharmaceutical partners.

Arvinas products and services overview:

Protein degrader drugs
Cancer therapies
Drug discovery
Clinical development
Research partnerships

Revenue: ~$137 million

Employees: 430

Headquarters: New Haven, United States (USA)

Arvinas is one of the...

Arvinas is a company listed under the stock ticker ARVN (US).

Executives

View the org chart displaying its 29 main executives

Most searched biographies at Arvinas

Popular executive movements at Arvinas

Randy Teel, who was Chief Business Officer, is promoted to Chief Executive Officer and Director (posted on February 17 2026).
John Houston who was Chairman of the Board, becomes Director (posted on February 17 2026).

Create your alert
to follow the executive moves at Arvinas.